| Identification of cardiac magnetic resonance imaging thresholds for risk stratification in pulmonary arterial hypertension RA Lewis, CS Johns, M Cogliano, D Capener, E Tubman, CA Elliot, ... American Journal of Respiratory and Critical Care Medicine 201 (4), 458-468, 2020 | 118 | 2020 |
| Cardiac-MRI predicts clinical worsening and mortality in pulmonary arterial hypertension: a systematic review and meta-analysis S Alabed, Y Shahin, P Garg, F Alandejani, CS Johns, RA Lewis, ... Cardiovascular Imaging 14 (5), 931-942, 2021 | 90 | 2021 |
| Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension RA Lewis, AAR Thompson, CG Billings, A Charalampopoulos, CA Elliot, ... European Respiratory Journal 55 (6), 2020 | 64 | 2020 |
| BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? RA Lewis, C Durrington, R Condliffe, DG Kiely European Respiratory Review 29 (156), 2020 | 61 | 2020 |
| Pathophysiology and diagnosis of pulmonary hypertension due to left heart disease A Charalampopoulos, R Lewis, P Hickey, C Durrington, C Elliot, ... Frontiers in medicine 5, 174, 2018 | 43 | 2018 |
| EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results … RA Lewis, I Armstrong, C Bergbaum, MJ Brewis, J Cannon, ... European Respiratory Journal 57 (2), 2021 | 37 | 2021 |
| Maximal exercise testing using the incremental shuttle walking test can be used to risk-stratify patients with pulmonary arterial hypertension RA Lewis, CG Billings, JA Hurdman, IA Smith, M Austin, IJ Armstrong, ... Annals of the American Thoracic Society 18 (1), 34-43, 2021 | 21 | 2021 |
| Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response ZM Goh, N Balasubramanian, S Alabed, K Dwivedi, Y Shahin, ... Heart 108 (17), 1392-1400, 2022 | 17 | 2022 |
| Right ventricular adaptation assessed using cardiac magnetic resonance predicts survival in pulmonary arterial hypertension ZM Goh, S Alabed, Y Shahin, AMK Rothman, P Garg, A Lawrie, ... Cardiovascular Imaging 14 (6), 1271-1272, 2021 | 15 | 2021 |
| Arrhythmic burden and outcomes in pulmonary arterial hypertension JT Middleton, A Maulik, R Lewis, DG Kiely, M Toshner, ... Frontiers in medicine 6, 169, 2019 | 15 | 2019 |
| The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry CG Billings, R Lewis, JA Hurdman, R Condliffe, CA Elliot, AAR Thompson, ... Pulmonary Circulation 9 (2), 2045894019848649, 2019 | 14 | 2019 |
| Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: a series of 90 patients from the ASPIRE registry RA Lewis, CG Billings, A Bolger, S Bowater, A Charalampopoulos, P Clift, ... Respirology 25 (10), 1066-1072, 2020 | 12 | 2020 |
| Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction P Garg, RA Lewis, CS Johns, AJ Swift, D Capener, S Rajaram, ... The International Journal of Cardiovascular Imaging 37 (10), 3019-3025, 2021 | 11 | 2021 |
| Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial … K Dwivedi, R Condliffe, M Sharkey, R Lewis, S Alabed, S Rajaram, C Hill, ... ERJ Open Research 8 (1), 2022 | 10 | 2022 |
| Imaging and risk stratification in pulmonary arterial hypertension: time to include right ventricular assessment F Alandejani, A Hameed, E Tubman, S Alabed, Y Shahin, RA Lewis, ... Frontiers in cardiovascular medicine 9, 797561, 2022 | 9 | 2022 |
| Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in World Health Organisation functional class I CG Billings, R Lewis, IJ Armstrong, JA Hurdman, IA Smith, M Austin, ... Frontiers in Medicine 5, 172, 2018 | 8 | 2018 |
| Mild parenchymal lung disease is still lung disease R Condliffe, DG Kiely, RA Lewis European Respiratory Journal 56 (5), 2020 | 4 | 2020 |
| Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis (Sep, 10.1016/j. jcmg. 2020.08. 013, 2021) S Alabed, Y Shahin, P Garg, F Alandejani, CS Johns, RA Lewis, ... JACC-CARDIOVASCULAR IMAGING 14 (4), 709-709, 2021 | 2 | 2021 |
| Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD) S Ramjug, C Billings, S Bowater, A Charalampopoulos, P Clift, C Elliot, ... European Respiratory Journal 54 (suppl 63), 2019 | 2 | 2019 |
| Cardiac MRI: identifying thresholds to predict mortality in pulmonary arterial hypertension R Lewis, M Cogliano, CS Johns, CG Billings, N Hamilton, CA Elliot, ... B27. HEARTBREAKER: HEART FAILURE AND PULMONARY HYPERTENSION, A2809-A2809, 2019 | 2 | 2019 |
David G KielyConsultant Respiratory Physician and Director Sheffield Pulmonary Vascular Disease UnitVerified email at sth.nhs.uk
